XBIO vs. LU

In the year-to-date period, XBIO achieves a -30.02% return, which is significantly lower than LU's 30.54% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Xenetic Biosciences, Inc. (XBIO) and Lufax Holding Ltd (LU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current XBIO Sharpe Ratio is -0.39, which is lower than the LU Sharpe Ratio of 0.81. The chart below compares the historical Sharpe Ratios of XBIO and LU, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

XBIO has not paid dividends to shareholders, while LU's dividend yield for the trailing twelve months is around 77.56%.

The maximum XBIO drawdown since its inception was -99.94%, roughly equal to the maximum LU drawdown of -96.68%. Use the drawdown chart below to compare losses from any high point for XBIO and LU. For additional features, visit the drawdowns tool.

Xenetic Biosciences, Inc. (XBIO) has a higher volatility of 26.28% compared to Lufax Holding Ltd (LU) at 22.06%. This indicates that XBIO's price experiences larger fluctuations and is considered to be riskier than LU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Xenetic Biosciences, Inc. and Lufax Holding Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.